98%
921
2 minutes
20
Modernizing traditional Chinese medicine (TCM) requires preserving its foundational principles while integrating contemporary innovations and clarifying therapeutic methods. Organoids and organoids-on-chip technologies offer advanced models of human organs, and serve as an excellent platform for investigating TCM theories and complex herbal formulas. To systematically summarize recent progress in using organoids and organoids-on-chip in TCM research, and critically assess their technical advantages and future potential, relevant articles and information were sourced from scientific databases such as PubMed, SpringerLink, Web of Science, ScienceDirect, and VIP. The application of organoids and organoids-on-chip technologies in TCM research encompasses theory interpretation, efficacy evaluation, mechanism elucidation, toxicity assessment, active ingredient screening, and formula optimization. These applications offer significant advantages, such as unveiling holistic effects, deciphering mechanistic bases through dynamic visualization approaches, and demonstrating personalized therapeutic benefits. Enhancing physiological relevance, automation, and intelligent applications are future development directions. Organoids and organoids-on-chip represent transformative tools for the modernization of TCM. Future advancements in vascularization, neural network development, and the integration of artificial intelligence are anticipated to address existing limitations, thereby enhancing physiological relevance and clinical translation. These advancements are expected to promote global acceptance and innovation in TCM.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/cbin.70067 | DOI Listing |
Cell Biol Int
August 2025
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Modernizing traditional Chinese medicine (TCM) requires preserving its foundational principles while integrating contemporary innovations and clarifying therapeutic methods. Organoids and organoids-on-chip technologies offer advanced models of human organs, and serve as an excellent platform for investigating TCM theories and complex herbal formulas. To systematically summarize recent progress in using organoids and organoids-on-chip in TCM research, and critically assess their technical advantages and future potential, relevant articles and information were sourced from scientific databases such as PubMed, SpringerLink, Web of Science, ScienceDirect, and VIP.
View Article and Find Full Text PDFPresse Med
July 2025
Univ. Grenoble Alpes, CEA, Inserm, IRIG, UA13 BGE, Biomics, Grenoble, France. Electronic address:
Type 1 Diabetes (T1D) is a highly complex and prevalent metabolic disease caused by dysfunctions of pancreatic islets. Over the past decade, diabetes research and treatments have focused on insulin restoration and glucose homeostasis, especially the regenerative approaches for stem cell based therapies for T1D. Nevertheless, unravelling the islet developmental processes and physiopathology of diabetes requires development of in vitro models that mimic the structure and function of islet of Langerhans.
View Article and Find Full Text PDFNatl Sci Rev
July 2025
Department of Orthodontics, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai 201100, China.
Muscle and bone have intimate biochemical associations spatiotemporally. Yet, the muscle-bone dynamic alterations under intermittent hypoxia (IH) remain unclear, primarily due to the lack of suitable microphysiological models. Herein, we developed a novel musculoskeletal organoids-on-chip (MSK OoC), advancing an integrated study of muscle-bone biochemical communication and personalized interventional strategies.
View Article and Find Full Text PDFIn Vitro Model
February 2025
College of Life Sciences, University of Chinese Academy of Sciences, No. 1 Yanqihu East Rd, Huairou District, 101408 Beijing PR China.
Organoids are three-dimensional, miniaturized tissue-like structures derived from either stem cells or primary cells, emerging as powerful in vitro models for studying developmental biology, disease pathology, and drug discovery. These organoids more accurately mimic cell-cell interactions and complexities of human tissues compared to traditional cell cultures. However, challenges such as limited nutrient supply and biomechanical cue replication hinder their maturation and viability.
View Article and Find Full Text PDFFront Bioeng Biotechnol
March 2025
Applied Stem Cell Technologies, Department of Bioengineering Technologies, University of Twente, Enschede, Netherlands.
Organoids are stem-cell derived tissue structures mimicking specific structural and functional characteristics of human organs. Despite significant advancements in the field over the last decade, challenges like limited long-term functional culture and lack of maturation are hampering the implementation of organoids in biomedical research. Culture of organoids in microfluidic chips is being used to tackle these challenges through dynamic and precise control over the organoid microenvironment.
View Article and Find Full Text PDF